Gregory Behar's Insider Trades & SAST Disclosures

Gregory Behar's most recent trade in Seres Therapeutics Inc was a trade of 35,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 22, 2022.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Seres Therapeutics Inc
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 35,000 35,000 - - Stock Option (right to buy)
Axcella Health Inc
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2021 20,000 20,000 - - Stock Option (Right to Buy)
Seres Therapeutics Inc
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2020 30,000 30,000 - - Stock Option (right to buy)
Axcella Health Inc
Gregory Behar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 May 2020 11,000 11,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades